Skip to main content
322 search results for:

Lubiprostone 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. Open Access 01-12-2024 | Lubiprostone | OriginalPaper

    Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm

    Constipation is a common gastrointestinal disorder characterized by persistently difficult, incomplete, or infrequent bowel movements [ 1 ]. Chronic constipation (CC), which is generally defined as symptoms persisting for at least 3 months …

  2. 01-06-2023 | Lubiprostone | News

    Lubiprostone

    Lack of efficacy: case report
  3. 01-11-2022 | Lubiprostone | News

    Lubiprostone

    Diarrhoea and pulmonary embolism: 2 case reports
  4. 01-07-2022 | Constipation | News

    Lubiprostone/risperidone/selegiline

    Constipation and pedal oedema: case report
  5. Open Access 01-06-2021 | Constipation | OriginalPaper

    Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation

    This article is published with digital features, including a summary slide, to facilitate understanding of the article. To view digital features for this article, go to https://doi.org/10.6084/m9.figshare.14199803 .

  6. Open Access 01-12-2022 | Lubiprostone | OriginalPaper

    Bowel preparation using 2-L split-dose polyethylene glycol regimen plus lubiprostone versus 4-L split-dose polyethylene glycol regimen: a randomized controlled trial

    Colon disease assessment and colorectal cancer screening currently rely on colonoscopy as the standard approach. Clear mucosal visualization, which depends on the quality of the bowel preparation, is essential for detecting lesions and may …

  7. Open Access 01-12-2020 | Lubiprostone | OriginalPaper

    Negative chronotropic and inotropic effects of lubiprostone on iPS cell-derived cardiomyocytes via activation of CFTR

    Lubiprostone (LBP) is an activator of the chloride channel protein 2 (ClC-2) and cystic fibrosis transmembrane conductance regulator (CFTR) channels. In the intestinal epithelium, LBP promotes intracellular Cl − and fluid secretion to the …

  8. 01-10-2020 | Constipation | OriginalPaper

    Effect of lubiprostone on vinca alkaloid–induced constipation in patients with hematological malignancies: a propensity score–matched analysis

    Patients receiving vinca alkaloids for hematological malignancies frequently experience constipation that is unresponsive to laxatives. Research on treatment of vinca alkaloid-induced constipation is limited. This study aimed to determine whether …

  9. 01-07-2019 | Nausea | News

    Lubiprostone

    Nausea and vomiting: 2 case reports
  10. Open Access 01-06-2021 | Constipation | Erratum

    Correction to: Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation

    A correction to this paper has been published: https://doi.org/10.1007/s12325-021-01776-w …

  11. Open Access 01-09-2018 | OriginalPaper

    The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation

    Chronic idiopathic constipation (CIC) is a common disorder characterized as constipation over an extended time period with no known cause. The most widely accepted definition of CIC uses the Rome IV diagnostic criteria [ 1 ], which requires that …

  12. 01-01-2017 | News

    Lubiprostone

    Diarrhoea: case report
  13. 01-04-2017 | OriginalPaper

    Laxatives, targeted therapy and lubiprostone are options when individualizing treatment for opioid-induced constipation in the elderly

    The optimal management of opioid-induced constipation (OIC) involves the use of laxatives as prophylaxis and first-line therapy, with diet, lifestyle and medication modifications where appropriate, and targeted therapy (e.g. peripherally acting …

  14. 01-06-2009 | OriginalPaper

    Lubiprostone

    In Constipation-Predominant Irritable Bowel Syndrome

    Lubiprostone is an oral bicyclic fatty acid that selectively activates type 2 chloride channels in the apical membrane of human gastrointestinal epithelial cells, thereby increasing chloride-rich fluid secretion. Although the mechanism is …

  15. 01-04-2006 | OriginalPaper

    Lubiprostone

    A Viewpoint by Michael Camilleri
  16. 01-04-2006 | OriginalPaper

    Lubiprostone

    A Viewpoint by Lawrence R. Schiller
  17. 01-04-2006 | OriginalPaper

    Lubiprostone

    Lubiprostone (Amitiza™) is an oral bicyclic fatty acid that selectively activates type 2 chloride channels in the apical membrane of the gastrointestinal epithelium, resulting in increased fluid secretion.▴ In two pivotal, randomised …

  18. 01-07-2005 | OriginalPaper

    Lubiprostone

    RU 0211, SPI 0211

    Lubiprostone [ RU 0211, SPI 0211 ] is a bicyclic fatty acid that acts as a chloride channel opener, increasing intestinal water secretion. Lubiprostone, an orally-administered formulation, is one of a series of functional fatty acid compounds …

  19. 01-03-2013 | News

    Lubiprostone

    Ischaemic colitis: case report
  20. 01-04-2012 | Abstract

    Lubiprostone

    Ischaemic colitis: case report

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.